MLchartDataset catalogue

Retacrit

Term · Oncology and biomedicine · MLC-T-ONC-007388

A drug used to treat anemia caused by chronic kidney disease, some types of chemotherapy, and an antiviral drug for HIV infection called zidovudine. It is also used to lower the number of donor blood transfusions needed during and after certain types of surgery. Retacrit is a form of erythropoietin (a substance naturally made by the kidneys) that is made in the laboratory. It helps the bone marrow make more red blood cells. Retacrit is a type of antianemic and a type of erythropoiesis-stimulating agent. Also called epoetin alfa, Epogen, and Procrit.

Table 1. Record
IdentifierMLC-T-ONC-007388
FieldOncology and biomedicine
Synonymsepoetin alfa; Epogen; Procrit
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007388",
  "term": "Retacrit",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat anemia caused by chronic kidney disease, some types of chemotherapy, and an antiviral drug for HIV infection called zidovudine. It is also used to lower the number of donor blood transfusions needed during and after certain types of surgery. Retacrit is a form of erythropoietin (a substance naturally made by the kidneys) that is made in the laboratory. It helps the bone marrow make more red blood cells. Retacrit is a type of antianemic and a type of erythropoiesis-stimulating agent. Also called epoetin alfa, Epogen, and Procrit.",
  "synonyms": [
    "epoetin alfa",
    "Epogen",
    "Procrit"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/retacrit/"
}

Record 14,390 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.